Skip to search formSkip to main contentSkip to account menu

GP 531

Known as: GP-531, GP531 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Aminoimidazole CarboxamideDeoxyribonucleosides
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Acute Intravenous Infusion of an Adenosine Regulating Agent Improves Left Ventricular Function in Dogs with Advanced Heart Failure
PurposeGP531 is a second generation adenosine regulating agent (ARA) that increases concentrations of endogenous adenosine, a… 
2010
2010
Cardioprotection With Adenosine-Regulating Agent, GP531: Effects on No-Reflow, Infarct Size, and Blood Flow Following Ischemia/ Reperfusion in the Rabbit
GP531, a potent, second-generation adenosine-regulating agent, is pharmacologically silent under basal conditions but increases… 
2009
2009
Abstract 3709: Intravenous GP531, an Adenosine Regulating Agent, Improves Left Ventricular Function in Dogs With Chronic Heart Failure
1997
1997
Cardioprotection with a novel adenosine regulating agent mediated by intravascular adenosine.
1996
1996
A sensitive assay for the aminoimidazole-containing drug GP531 in plasma using liquid chromatography with amperometric electrochemical detection: a new class of electroactive compounds.
1996
1996
Spectrophotometric determination of the cardioprotective drug GP531 in human plasma.
1995
1995
Pharmacokinetics and tolerance of a novel anti-thrombotic and anti-ischemic agent GP531 following a 6 hr iv infusion in healthy male and female volunteers
1995
1995
727-3 Regulation of Endogenous Adenosine Improves Myocardial Functional Recovery Following Ischemia/Reperfusion Injury
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)